{{Rsnum
|rsid=6059244
|Gene=DEFB122
|Chromosome=20
|position=31422680
|Orientation=plus
|GMAF=0.376
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=DEFB122
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 9.0 | 53.2 | 37.8
| HCB | 7.4 | 41.2 | 51.5
| JPT | 9.7 | 33.6 | 56.6
| YRI | 32.0 | 50.3 | 17.7
| ASW | 24.6 | 56.1 | 19.3
| CHB | 7.4 | 41.2 | 51.5
| CHD | 7.3 | 32.1 | 60.6
| GIH | 6.0 | 42.0 | 52.0
| LWK | 20.6 | 46.7 | 32.7
| MEX | 14.0 | 40.4 | 45.6
| MKK | 16.0 | 42.3 | 41.7
| TSI | 7.8 | 53.9 | 38.2
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs6059244
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363838
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6059244
|overall_frequency_n=84
|overall_frequency_d=128
|overall_frequency=0.65625
|n_genomes=47
|n_genomes_annotated=0
|n_haplomes=71
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}